Shots:
- The acquisition will utilize Tepha’s resorbable polymer technology to boost the growth of BD’s surgical mesh portfolio for the repair and regeneration of soft tissues
- The acquisition also provides strategic vertical integration for BD’s Phasix mesh products & includes Tepha’s GalaFLEX portfolio which is based on the novel P4HB polymer
- Additionally, an interventional segment of BD plans to extend the use of Tepha’s technology to multiple medical applications & helps the transformation of soft tissue repair and regeneration
Click here to read full press release/ article | Ref: PR Newswire | Image: Seeking Alpha
The post BD Acquires Tepha to Boost its Surgical Mesh Portfolio first appeared on PharmaShots.
